| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sino Biopharmaceutical Limited (STU: SMZ1)
SMZ1 Technical Analysis
5
| As on 26th Jun 2025 SMZ1 STOCK Price closed @ 0.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.35 & Strong Buy for SHORT-TERM with Stoploss of 0.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SMZ1STOCK Price
| Open | 0.55 | Change | Price | % |
| High | 0.55 | 1 Day | -0.01 | -1.79 |
| Low | 0.55 | 1 Week | 0.01 | 1.85 |
| Close | 0.55 | 1 Month | 0.12 | 27.91 |
| Volume | 25000 | 1 Year | 0.19 | 52.78 |
| 52 Week High 0.61 | 52 Week Low 0.27 | ||||
STU Germany Most Active Stocks
| POQ | 0.01 | % |
| POQ | 0.01 | % |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TINC | 0.01 | -1.50% |
| PGF | 19.13 | -90.20% |
| PGF | 19.13 | -90.20% |
STU Germany Top Gainers Stocks
STU Germany Top Losers Stocks
| SMZ1 Daily Charts |
SMZ1 Intraday Charts |
Whats New @ Bazaartrend |
SMZ1 Free Analysis |
|
|
SMZ1 Important Levels Intraday
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.55 |
SMZ1 Forecast June 2025
| 4th UP Forecast | 0.67 |
| 3rd UP Forecast | 0.63 |
| 2nd UP Forecast | 0.61 |
| 1st UP Forecast | 0.58 |
| 1st DOWN Forecast | 0.52 |
| 2nd DOWN Forecast | 0.49 |
| 3rd DOWN Forecast | 0.47 |
| 4th DOWN Forecast | 0.43 |
SMZ1 Weekly Forecast
| 4th UP Forecast | 0.61 |
| 3rd UP Forecast | 0.59 |
| 2nd UP Forecast | 0.58 |
| 1st UP Forecast | 0.57 |
| 1st DOWN Forecast | 0.53 |
| 2nd DOWN Forecast | 0.52 |
| 3rd DOWN Forecast | 0.51 |
| 4th DOWN Forecast | 0.49 |
SMZ1 Forecast2025
| 4th UP Forecast | 1.21 |
| 3rd UP Forecast | 1 |
| 2nd UP Forecast | 0.87 |
| 1st UP Forecast | 0.74 |
| 1st DOWN Forecast | 0.36 |
| 2nd DOWN Forecast | 0.23 |
| 3rd DOWN Forecast | 0.1 |
| 4th DOWN Forecast | -0.11 |
Sino Biopharmaceutical Limited ( STU Germany Symbol : SMZ1 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
SMZ1 Business Profile
Sino Biopharmaceutical Limited, an investment holding company, researches and develops, produces, and sells Chinese and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in three segments: Chemical Medicines and Biopharmaceutical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianding tablets, Tianqingganping enteric capsules, Mingzheng capsules, and Ganze entecavir capsules; cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Kaina tablets, and Tianqingning injections; and oncology medicines consisting of Saiweijian, Tianqingyitai, Qingweike, and Zhiruo injections, as well as Focus V and Genike capsules, and Shoufu and Yinishu tablets. The company's principal products also comprise Analgesic medicines, such as Kaifen injections and Debaian Cataplasms; Orthopedic medicines, which include Gaisanchun capsules and Jiuli tablets; digestive system medicines, such as Aisuping injections and Getai tablets; anti-infectious medicines consisting of Tiance injections and Tianjie tablets; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections. In addition, it is involved in the development of medicines for tumor, liver, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management and healthy information services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service